Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 13, 2023

BUY
$9.9 - $12.43 $295,445 - $370,948
29,843 New
29,843 $369,000
Q2 2022

Aug 04, 2022

SELL
$11.05 - $12.72 $166,899 - $192,122
-15,104 Closed
0 $0
Q1 2022

May 11, 2022

SELL
$10.61 - $12.88 $34,556 - $41,950
-3,257 Reduced 17.74%
15,104 $190,000
Q4 2021

Feb 14, 2022

SELL
$10.86 - $13.95 $526,807 - $676,700
-48,509 Reduced 72.54%
18,361 $214,000
Q3 2021

Nov 15, 2021

BUY
$11.92 - $13.92 $797,090 - $930,830
66,870 New
66,870 $873,000

Others Institutions Holding IRWD

About IRONWOOD PHARMACEUTICALS INC


  • Ticker IRWD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 153,231,008
  • Market Cap $682M
  • Description
  • Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...
More about IRWD
Track This Portfolio

Track Seven Eight Capital, LP Portfolio

Follow Seven Eight Capital, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Seven Eight Capital, LP, based on Form 13F filings with the SEC.

News

Stay updated on Seven Eight Capital, LP with notifications on news.